Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Zachary C. Rosenthal, Stephen J. Haggarty, Daniel M. Fass et al.|Scientific Reports|2024

Cited by 11